Background: Recently. modification of T cells with chimeric antigen receptor (CAR) has been an attractive approach for adoptive immunotherapy of cancers. Typically. CARs contain a single-chain variable domain fragment (scFv). https://macorners.shop/product-category/window-hanging-luminous-ornament/